瑞马唑仑与丙泊酚用于电视辅助胸腔镜手术麻醉诱导的多中心随机对照试验研究方案
本研究为前瞻性多中心随机对照试验,计划纳入172例45至65岁行电视辅助胸腔镜手术的患者,随机接受瑞马唑仑或丙泊酚诱导,主要结局为诱导后20分钟内低血压发生率,旨在比较两者血流动力学效应。
要点
- 瑞马唑仑是新型超短效静脉镇静催眠药,可能促进血流动力学稳定。
- 主要结局为麻醉诱导后20分钟内低血压发生率,低血压定义为收缩压低于90 mmHg或较基线下降超过30%或需使用血管活性药物。
- 迄今瑞马唑仑很少用于电视辅助胸腔镜手术麻醉诱导,本研究将提供该手术场景下血流动力学稳定性和麻醉效能的重要信息。
核心结论
- 本研究旨在比较瑞马唑仑与丙泊酚在电视辅助胸腔镜手术患者麻醉诱导期间的血流动力学效应。
研究设计与样本
- 前瞻性、多中心随机对照试验,计划纳入172例45至65岁行电视辅助胸腔镜手术的患者,随机分配接受瑞马唑仑或丙泊酚进行麻醉诱导。
主要发现
- 主要结局为麻醉诱导后20分钟内低血压发生率,低血压定义为收缩压低于90 mmHg,或收缩压较基线下降超过30%,或使用血管活性药物。
- 次要结局包括镇静成功率、成功镇静时间、诱导期咳嗽、术后7天内谵妄及术后住院期间死亡率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative hypotension may result in a higher incidence of postoperative myocardial injury, acute kidney injury, and stroke. Notably, more than half of intraoperative hypotension cases occur immediately after induction of general anesthesia. Although intraoperative hypotension has multiple causes, post-induction hypotension is primarily due to the effects of anesthetic drugs. Propofol is the most widely used agent for anesthesia induction. However, propofol can induce hemodynamic instability, potentially leading to adverse postoperative outcomes. Remimazolam, a novel ultra-short-acting intravenous sedative-hypnotic, may promote stable hemodynamics. Studies have reported that remimazolam is associated with less hypotension compared to propofol. Therefore, this study aims to compare the hemodynamic effects of remimazolam and propofol during anesthesia induction in patients undergoing video-assisted thoracoscopic surgery. METHODS: This is a prospective, multicenter randomized controlled trial. A total of 172 patients aged 45 to 65 years undergoing video-assisted thoracoscopic surgery will be randomly allocated to receive remimazolam or propofol during anesthetic induction. The primary outcome is the incidence of hypotension occurring within 20 min after anesthesia induction. Hypotension is defined as systolic blood pressure (SBP) of less than 90 mmHg, or a reduction of more than 30% in SBP from baseline, or the administration of vasoactive medication. Secondary outcomes include the rate of successful sedation, time to successful sedation, coughing during the induction period, postoperative delirium within 7 days after surgery, and postoperative in-hospital mortality. DISCUSSION: To date, remimazolam has rarely been used for anesthesia induction in video-assisted thoracoscopic surgery. This study will provide important information on hemodynamic stability and anesthesia efficacy of remimazolam in this surgical setting. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2400085556. Registered on 12 th June 2024, http://www.chictr.org.cn/ .
引用
- Zhang L, Yang J, Zhou L, et al. The use of remimazolam versus propofol for anesthesia induction in video-assisted thoracoscopic surgery: study protocol for a multicenter randomized controlled trial. Trials. 2025. PMID: 40420204. doi:10.1186/s13063-025-08833-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。